His control over others is starting to fray as Bryan Johnson, a longevity guru known for performing experiments on his body, ...
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Revolt CEO Detavio Samuels explains how the linear TV and digital brand is adapting on the Variety podcast 'Strictly Business ...
With her debut book and a career built on disruption, the strategist-turned-author is handing us a blueprint to enact change ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...
In this age of AI and Magnificent 7 tech stock price volatility, Dividend King stocks still stand apart in the eyes of many ...
The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.
Johnson & Johnson (NYSE:JNJ) holds one of the longest dividend growth track records in the market, spanning over 62 years.
It's manufactured by one of the biggest names in personal care and marketed for its nontoxic ingredients. Here's what's in ...
Lack of products that precisely match skin tones are often said to be evidence of “white privilege,” yet the market division ...
Three Motley Fool contributors think they've found relatively safe stocks to buy right now with major market indexes remaining near correction territory. Here's why they like Abbott Laboratories (NYSE ...